Skip to main content

Day: May 7, 2021

Borqs Technologies Completes $23 Million Private Placement to Support Growth

SANTA CLARA, Calif., May 07, 2021 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, the “Company”), a global provider of embedded software and products for the Internet of Things (IoT), reported today that the Company has completed sales of $15.3 million in convertible notes to institutional and individual investors as of May 5, 2021, which in addition to $7.7 million sold to the same investors in February and April, totaled $23 million. The notes have a two-year term and an annual interest rate of 8%. The conversion price was reset to $0.972 per share, which was 90% of the closing price on the day effectiveness of registration was declared. The Company also issued 11,695,906 five-year warrants with an exercise price of $2.222 per share and 2,521,008 five-year warrants with an exercise price of $1.540 per share. The shares...

Continue reading

Medicenna Announces the Peer-Reviewed Publication of Clinical Data from Phase 2b Trial Evaluating MDNA55 in Recurrent Glioblastoma

— Data published in Clinical Cancer Research indicate that early determination of PFS with modified RANO criteria may be a strong surrogate for overall survival in recurrent glioblastoma — Medicenna’s proposed patient population shows a tumor control rate of 81% (26/32) based on modified RANO criteria TORONTO and HOUSTON, May 07, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced the peer-reviewed publication of clinical data from the Company’s Phase 2b recurrent glioblastoma (rGBM) trial in Clinical Cancer Research. The paper, entitled “Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-enhanced Delivery of IL4R-targeted Immunotoxin MDNA55 in Recurrent Glioblastoma,” was published...

Continue reading

HUMBL Announces Binding Term Sheet to Acquire Monster Creative

San Diego, California, May 07, 2021 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC Markets: HMBL) announced today that it has entered into a binding term sheet to acquire Monster Creative, LLC. Founded by award-winning industry veterans Doug Brandt and Kevin Childress, Monster Creative is a leading creative advertising agency in the entertainment space. Monster Creative will continue independent operations of its Hollywood studios while collaborating with HUMBL in creating multimedia NFTs and ticketing experiences for clients in sports, music, entertainment, fashion, gaming, and photography. “We are honored to work with such highly regarded Hollywood veterans, to create world class, immersive multimedia NFTs and ticketing experiences for clients and fans in the digital realm,” said Brian Foote, CEO of HUMBL. Throughout their careers Brandt...

Continue reading

180 Degree Capital Corp. to Report First Quarter 2021 Financial Results on Tuesday, May 11, 2021, and to Host a Conference Call on Wednesday, May 12, 2021

MONTCLAIR, N.J., May 07, 2021 (GLOBE NEWSWIRE) — 180 Degree Capital Corp. (NASDAQ: TURN) will announce its first quarter 2021 financial results on Tuesday, May 11, 2021, shortly after the close of the public markets. It will host a conference call on Wednesday, May 12, 2021, at 9am Eastern Time to discuss these results and updates from Q2 2021.  The dial-in information for the call is noted below: U.S. Domestic Dial-In Number: (712) 770-4598 International Dial-In Numbers: https://d1io3yog0oux5.cloudfront.net/180degreecapital/files/International-Dial-In-Numbers-4-2019.pdf Passcode: 415049 Webcast: https://www.freeconferencecall.com/wall/180degreecapital Presentation materials along with a replay of the meeting will be available on the Company’s investor relations website at https://ir.180degreecapital.com/ir-calendar. About...

Continue reading

General Cannabis Names Interim CEO; Steve Gutterman Steps Down

General Cannabis Board Member and major investor, Adam Hershey, to be appointed Interim CEOSearch for new CEO to begin immediatelyDENVER, May 07, 2021 (GLOBE NEWSWIRE) — General Cannabis Corp (OTCQB: CANN) today announced several changes to its executive management team. Current Board Member and major investor, Adam Hershey, was appointed as the Company’s Interim CEO. Steve Gutterman stepped down from his CEO and Director roles and will be leaving the Company to pursue other opportunities, effective immediately. Tim Brown, Founder and CEO of Trees, will be joining the Board upon the first closing of the recently announced foundational Trees acquisition. Richard Travia, current Independent Board Member, has been named Lead Independent Director and has initiated a comprehensive search process to select a permanent CEO to lead...

Continue reading

Palisade Bio and Newsoara Announce Completion of Phase 2 Study in GI Surgery Study in China

Topline results expected in H1-2021 CARLSBAD, Calif. and SHANGHAI, China, May 07, 2021 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), and co-development partner Newsoara today announce completion of a Phase 2 clinical trial evaluating lead drug candidate LB1148 for accelerating return of bowel function associated with gastrointestinal (GI) surgery. The PROFILE study in China is a randomized, double-blind, multicenter, Phase 2 trial that has enrolled over 120 patients undergoing elective bowel resection. Patients received an oral dose of LB1148 prior to surgery. The primary endpoint of clinical efficacy is the time to return of bowel function. “Completing the PROFILE study in China is a significant milestone for Palisade Bio in our mission to bring innovative treatments to the millions of people undergoing gastrointestinal...

Continue reading

Auris Medical Provides Update on Bentrio Program in Allergy

BentrioTM meets primary efficacy endpoint in clinical evaluation in allergic rhinitis Clinically relevant and significant reduction in nasal symptoms Superior efficacy ratings by patients and clinicians    Pre-submission meeting with FDA supports 510(k) regulatory pathwayHamilton, Bermuda, May 7, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, and its affiliate Altamira Medica Ltd. today announced additional details on the outcomes from the clinical investigation of its BentrioTM nasal spray in allergic rhinitis and provided an update on the regulatory pathway in the US for the intended use in allergy. BentrioTM effectively alleviates allergy symptoms in clinical pollen challenge BentrioTM...

Continue reading

Baozun Announces Shareholder Resolutions Adopted at 2021 Annual General Meeting of Shareholders

SHANGHAI, China, May 07, 2021 (GLOBE NEWSWIRE) — Baozun Inc. (NASDAQ: BZUN and HKEX: 9991) (“Baozun” or the “Company”), the leading brand e-commerce service partner that helps brands execute their e-commerce strategies in China, announced today that the following shareholder resolutions were adopted and passed at its annual general meeting of shareholders held on May 7, 2021 in Shanghai, China:BY WAY OF A SPECIAL RESOLUTION, that the Fourth Amended and Restated Memorandum and Articles of Association currently in effect be amended and restated by the deletion in their entirety and the substitution in their place of the Fifth Amended and Restated Memorandum and Articles of Association of the Company in the form attached as Annex A to the proxy statement, and reflecting the updates as detailed in the proxy statement;BY WAY OF...

Continue reading

Edible Animal Fat Market to Reach USD 63.98 Billion by 2028; Increasing Demand for Sustainable Animal Fat Oil to Aid Growth, Says Fortune Business Insights™

Top companies covered in edible animal fat market are Ten Kate Holdings (Musselkanaal, Netherlands), Cargill, Inc. (Wayzata, United States), Darling Ingredients, Inc. (Irving, United States), Archer Daniels Midland Company (Chicago, United States), Bunge Limited (Chesterfield, United States), Sanimax (Montréal, Canada), Baker Commodities Inc. (Vernon, United States), York Foods Pty Ltd (Goulburn, Australia), Saria Group (Selm, Germany), Colyer Fehr Tallow Pty Ltd. (Mount Druitt, Australia), and more players profiled. Pune, India, May 07, 2021 (GLOBE NEWSWIRE) — The global edible animal fat market size is expected to experience significant growth by reaching USD 63.98 billion by 2028. Fortune Business Insights in its latest report, titled, “Edible Animal Fat Market, 2021 – 2028.”, mentions that the market stood at USD 41.50 billion...

Continue reading

Freddie Mac Announces 2021 Home Possible RISE Award Winners for Helping Very Low- to Low-Income Homebuyers

MCLEAN, Va., May 07, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today announced the winners of its Home Possible RISE Awards®. The annual program, RISE (Recognizing Individuals for Sustained Excellence), salutes Freddie Mac’s top clients across multiple categories for excellence with Home Possible® mortgages – Freddie Mac’s affordable lending solution for very low- to low-income homebuyers. “This year’s Home Possible RISE award winners are to be commended as the pandemic weighed heavily on the industry, and the country,” said Danny Gardner, Senior Vice President, Client and Community Engagement. “We thank all our lender partners for their dedication and celebrate their efforts to expand responsible, sustainable homeownership.” This year’s award winners represent national and local lending companies, as well as their...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.